Skip to content
MedsAcross

Medicine

Piperacillin and Tazobactam 2 g/0.25 g powder for injection

Available on requestPrescription onlyUS FDAGeneric name

Piperacillin and Tazobactam 2 g/0.25 g powder for injection is a generic prescription medicine for intravenous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Piperacillin and Tazobactam
Brand
Sold under the generic name
Strength
2 g/0.25 g
Dosage form
Powder for injection
Route
Intravenous
Packs
10 vials
Manufacturers
EugiaIndiaWG Critical Care
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.10Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
13 October 2009
Identifiers
RxCUI 1659131, 1659137, 1659149DailyMed set ID a5d8625e-e630-4076-bc55-46ebe861c6a5, 39e19789-de4b-4fd1-ab1c-92f59496f496, 2cd82553-79dc-45f0-9755-2c08df524ed5NDC 55150-119, 44567-801Application ANDA065498, ANDA065523

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
10 vial in 1 box / 1 injection, powder, lyophilized, for solution in 1 vial55150-119-09EugiaIndia23 January 2012
10 vial in 1 box / 1 injection, powder, lyophilized, for solution in 1 vial55150-119-30EugiaIndia23 January 2012
10 vial in 1 box / 1 injection, powder, for solution in 1 vial44567-801-10WG Critical Care13 October 2009

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 22 October 1993Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Piperacillin and Tazobactam

Clinical summary

Piperacillin and Tazobactam is a fixed-dose combination of a penicillin-class antibacterial and a beta lactamase inhibitor indicated for the treatment of intra-abdominal infections in adult and pediatric patients 2 months of age and older. MedsAcross supplies Piperacillin and Tazobactam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Piperacillin and Tazobactam

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Piperacillin and Tazobactam 2 g/0.25 g powder for injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.